MIR548Y

Across TCGA pan-cancer cohorts, MIR548Y RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR548Y data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR548Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548Y expression acts as an unfavorable survival marker, although some lineages such as LIHC and SKCM show a favorable association.

LUAD, KICH, and KIRC are the cancer types where MIR548Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.638	0.818	.006	63	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	51	view →
KIRC	DFS	Tertile	IV	0.092	0.620	.002	36	view →
THYM	OS	Tertile	II,III,IV	0.549	0.960	.011	18	view →
KIRP	DFS	Tertile	All	0.611	0.923	.006	18	view →
UCEC	DFS	Tertile	All	0.814	0.898	.032	18	view →
STAD	OS	Tertile	II,III,IV	0.506	0.727	.042	12	view →
LIHC	DFS	Tertile	III,IV	1.000	0.148	.027	12	view →
LGG	OS	Tertile	All	0.316	0.530	.010	9	view →
SKCM	DFS	Tertile	III,IV	0.641	0.202	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR548Y–LUAD (OS)

Open the LUAD breakdown →